CN105154499B - L-天门冬氨酸-l-鸟氨酸的制备方法 - Google Patents
L-天门冬氨酸-l-鸟氨酸的制备方法 Download PDFInfo
- Publication number
- CN105154499B CN105154499B CN201510635360.3A CN201510635360A CN105154499B CN 105154499 B CN105154499 B CN 105154499B CN 201510635360 A CN201510635360 A CN 201510635360A CN 105154499 B CN105154499 B CN 105154499B
- Authority
- CN
- China
- Prior art keywords
- aspartic acid
- added
- arginine
- solution
- ornithine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960003104 ornithine Drugs 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 238000006243 chemical reaction Methods 0.000 claims abstract description 111
- 102000004190 Enzymes Human genes 0.000 claims abstract description 55
- 108090000790 Enzymes Proteins 0.000 claims abstract description 55
- 235000014852 L-arginine Nutrition 0.000 claims abstract description 46
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims abstract description 43
- 229930064664 L-arginine Natural products 0.000 claims abstract description 40
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- 238000001976 enzyme digestion Methods 0.000 claims abstract description 32
- 239000008367 deionised water Substances 0.000 claims abstract description 31
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 31
- 238000001914 filtration Methods 0.000 claims abstract description 31
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000004793 Polystyrene Substances 0.000 claims abstract description 21
- 239000012530 fluid Substances 0.000 claims abstract description 21
- 239000004005 microsphere Substances 0.000 claims abstract description 21
- 229920002223 polystyrene Polymers 0.000 claims abstract description 21
- 239000002253 acid Substances 0.000 claims abstract description 16
- 235000003704 aspartic acid Nutrition 0.000 claims abstract description 16
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical class OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 10
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003957 anion exchange resin Substances 0.000 claims abstract description 7
- 239000003054 catalyst Substances 0.000 claims abstract description 6
- 229940071125 manganese acetate Drugs 0.000 claims abstract description 6
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 claims abstract description 6
- 102000004452 Arginase Human genes 0.000 claims abstract description 4
- 108700024123 Arginases Proteins 0.000 claims abstract description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000005864 Sulphur Substances 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 33
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 18
- 239000004202 carbamide Substances 0.000 claims description 18
- 239000007853 buffer solution Substances 0.000 claims description 16
- 239000003729 cation exchange resin Substances 0.000 claims description 14
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000000969 carrier Substances 0.000 claims description 8
- 238000004132 cross linking Methods 0.000 claims description 8
- 229940099596 manganese sulfate Drugs 0.000 claims description 8
- 239000011702 manganese sulphate Substances 0.000 claims description 8
- 235000007079 manganese sulphate Nutrition 0.000 claims description 8
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 8
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 8
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 4
- 238000010792 warming Methods 0.000 claims description 3
- 230000003750 conditioning effect Effects 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 claims 1
- 230000007071 enzymatic hydrolysis Effects 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 239000000376 reactant Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 abstract description 2
- 150000001413 amino acids Chemical class 0.000 abstract description 2
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- KNLQKHUBPCXPQD-UHFFFAOYSA-N manganese;sulfuric acid Chemical compound [Mn].OS(O)(=O)=O KNLQKHUBPCXPQD-UHFFFAOYSA-N 0.000 abstract 1
- 239000000047 product Substances 0.000 description 25
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 238000001514 detection method Methods 0.000 description 19
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 14
- 239000011347 resin Substances 0.000 description 12
- 229920005989 resin Polymers 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 150000001450 anions Chemical class 0.000 description 9
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 8
- 238000002425 crystallisation Methods 0.000 description 8
- 230000008025 crystallization Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 229910019142 PO4 Inorganic materials 0.000 description 7
- 229910021529 ammonia Inorganic materials 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 7
- 238000010828 elution Methods 0.000 description 7
- 150000008535 L-arginines Chemical class 0.000 description 6
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 150000001510 aspartic acids Chemical class 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000003643 water by type Substances 0.000 description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 235000009697 arginine Nutrition 0.000 description 4
- 229940023913 cation exchange resins Drugs 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 208000007386 hepatic encephalopathy Diseases 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000000825 ultraviolet detection Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 206010010075 Coma hepatic Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 150000008536 L-asparagines Chemical class 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 229910001422 barium ion Inorganic materials 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 201000001059 hepatic coma Diseases 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000370738 Chlorion Species 0.000 description 1
- 206010010305 Confusional state Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000004209 confusion Diseases 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 231100000004 severe toxicity Toxicity 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
批次 | 酶解反应转化时间 | 酶解反应转化率 | 终产品总收率 | 终产品含量 |
1 | 2h | 99.38% | 86.94% | 98.53% |
2 | 3h | 99.43% | 86.01% | 98.66% |
3 | 3h | 99.26% | 86.25% | 98.57% |
4 | 3h | 99.18% | 87.67% | 98.55% |
5 | 4h | 99.34% | 87.11% | 98.57% |
6 | 4h | 99.28% | 87.52% | 98.68% |
7 | 5h | 99.16% | 86.50% | 98.62% |
8 | 5h | 99.24% | 88.28% | 98.76% |
9 | 5h | 99.08% | 89.63% | 99.02% |
10 | 5h | 99.13% | 88.55% | 99.43% |
编号 | 总收率(%) | 终产品含量(%,液相外标法) | 比旋光度[α]D 20 |
实施例1 | 86.9% | 99.0 | +27.1 |
实施例2 | 86.3% | 98.7 | +27.8 |
实施例3 | 86.7% | 98.8 | +27.9 |
实施例4 | 83.2% | 98.3 | +26.8 |
实施例5 | 81.8% | 97.9 | +26.3 |
实施例6 | 80.5% | 98.1 | +26.5 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510635360.3A CN105154499B (zh) | 2015-09-30 | 2015-09-30 | L-天门冬氨酸-l-鸟氨酸的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510635360.3A CN105154499B (zh) | 2015-09-30 | 2015-09-30 | L-天门冬氨酸-l-鸟氨酸的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105154499A CN105154499A (zh) | 2015-12-16 |
CN105154499B true CN105154499B (zh) | 2018-11-09 |
Family
ID=54795542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510635360.3A Active CN105154499B (zh) | 2015-09-30 | 2015-09-30 | L-天门冬氨酸-l-鸟氨酸的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105154499B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110590919B (zh) * | 2017-05-24 | 2022-05-24 | 中国海洋大学 | 含鸟氨酸的短肽及其应用 |
CN107540413A (zh) * | 2017-09-14 | 2018-01-05 | 精晶药业股份有限公司 | 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法 |
CN107522629A (zh) * | 2017-10-12 | 2017-12-29 | 福建金山生物制药股份有限公司 | 一种门冬氨酸鸟氨酸的制备方法 |
CN108440324B (zh) * | 2018-04-19 | 2021-04-20 | 成都倍特药业股份有限公司 | 一种门冬氨酸鸟氨酸及其结晶方法 |
CN112342253A (zh) * | 2020-11-10 | 2021-02-09 | 湖南天成生化科技有限公司 | 高收率l-精氨酸硝酸盐的制备方法 |
CN113336663B (zh) * | 2021-06-04 | 2023-08-22 | 无锡晶海氨基酸股份有限公司 | 一种利用鸟氨酸催化液制备门冬氨酸鸟氨酸的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102041282A (zh) * | 2009-10-14 | 2011-05-04 | 新沂市汉菱生物工程有限公司 | 酶法制备l-鸟氨酸的方法 |
CN102102118A (zh) * | 2009-12-18 | 2011-06-22 | 上海汉飞生化科技有限公司 | 一种l-鸟氨酸-l-天门冬氨酸盐的制备方法 |
CN102286602A (zh) * | 2011-09-16 | 2011-12-21 | 天津启仁医药科技有限公司 | 微生物酶法拆分dl-精氨酸制备d-精氨酸盐酸盐和l-鸟氨酸盐酸盐的方法 |
-
2015
- 2015-09-30 CN CN201510635360.3A patent/CN105154499B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102041282A (zh) * | 2009-10-14 | 2011-05-04 | 新沂市汉菱生物工程有限公司 | 酶法制备l-鸟氨酸的方法 |
CN102102118A (zh) * | 2009-12-18 | 2011-06-22 | 上海汉飞生化科技有限公司 | 一种l-鸟氨酸-l-天门冬氨酸盐的制备方法 |
CN102286602A (zh) * | 2011-09-16 | 2011-12-21 | 天津启仁医药科技有限公司 | 微生物酶法拆分dl-精氨酸制备d-精氨酸盐酸盐和l-鸟氨酸盐酸盐的方法 |
Non-Patent Citations (1)
Title |
---|
高分子大孔微球的制备和结构控制;周炜清等;《化工学报》;20150701;第66卷(第8期);摘要,第2851-2853页2.2节 * |
Also Published As
Publication number | Publication date |
---|---|
CN105154499A (zh) | 2015-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105154499B (zh) | L-天门冬氨酸-l-鸟氨酸的制备方法 | |
CN103285837B (zh) | 对不同重金属离子具有高度选择性吸附材料的制备方法 | |
CN111039832B (zh) | 生产牛磺酸的方法及从牛磺酸制备的反应体系中除去杂质的方法 | |
US20230167474A1 (en) | Methods for enzymatic production of glucosamine salts and the purification methods thereof | |
CN111392697B (zh) | 一种对乙酰氨基苯磺酰氯合成中有机废酸的处理方法 | |
JPS6329999B2 (zh) | ||
CN108329239B (zh) | 一种由羟乙基磺酸钠制备牛磺酸的方法 | |
CN104892710B (zh) | 一种纯化还原型β‑烟酰胺腺嘌呤二核苷酸的方法 | |
US10765967B2 (en) | Process for purifying NADPH | |
CN101456903A (zh) | 万古霉素的分离纯化方法 | |
CN111454305A (zh) | 一种利用苯硼酸基载体定向辅助乳糖异构化制备并分离纯化乳果糖的方法 | |
CN104211739B (zh) | 一种泰乐菌素的精制方法 | |
CN105536832B (zh) | 介孔磷酸铌催化剂的制备方法及其在山梨醇制异山梨醇中的应用 | |
CN109553650A (zh) | 红霉素发酵液的水相提取方法 | |
CN106674122A (zh) | 一种5‑对羟基苯基乙内酰脲的制备方法 | |
CN107032983B (zh) | 一种利用大孔吸附树脂从发酵液中提取分离琥珀酸的方法 | |
CN106220646B (zh) | 一种酶法合成头孢氨苄母液的循环利用的方法 | |
CN105295059A (zh) | 一种固载阳离子化β-环糊精的氯甲基化聚苯乙烯聚合物及吸附回收工业废水中酚类的方法 | |
CN104152508A (zh) | 直接从生产栀子黄色素的废液中提取京尼平的方法 | |
CN104313071B (zh) | 高纯L‑α‑氨基酸的生物合成方法 | |
CN101607893B (zh) | 从食用级枸橼酸获得药用级枸橼酸的方法 | |
CN114805255A (zh) | 一种5-羟甲基糠醛的制备及膜分离纯化方法 | |
CN100361724C (zh) | 一种n-乙酰乙酰替苯胺生产废水的处理方法 | |
CN111065644B (zh) | 一种制备高纯度nad的方法 | |
CN113354702B (zh) | 一种高纯nadp的分离提纯工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of L-aspartate L-ornithine Effective date of registration: 20230418 Granted publication date: 20181109 Pledgee: Hebei Ningjin Rural Commercial Bank Co.,Ltd. Pledgor: JING JING PHARMACEUTICAL Co.,Ltd. Registration number: Y2023980038366 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231114 Granted publication date: 20181109 Pledgee: Hebei Ningjin Rural Commercial Bank Co.,Ltd. Pledgor: JING JING PHARMACEUTICAL Co.,Ltd. Registration number: Y2023980038366 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of L-aspartate L-ornithine Effective date of registration: 20231204 Granted publication date: 20181109 Pledgee: Hebei Ningjin Rural Commercial Bank Co.,Ltd. Pledgor: JING JING PHARMACEUTICAL Co.,Ltd. Registration number: Y2023980069369 |